Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]

Name: Methylphenidate 17.3 MG Disintegrating Oral Tablet Price Comparison: Uses, Dosage, Form & Side Effects
Creator: gmedication.com
Published: 2021-11-01T10:10:10+00:00

Was this drug effective for your ailment?

Here is the some steps to help you to save money on Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] purchase.

Read drug prescription

What is Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]
Important safety information:
Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] side effects

Select the most affordable brand or generic drug
Frequently asked Questions

Who should not take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]?
How should I take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]?

Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] reviews

Read drug prescription

What is Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]

Treating attention deficit disorders. It is also used to treat uncontrollable periods of daytime sleep (narcolepsy). It may also be used for other conditions as determined by your doctor.
Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] is a central nervous system stimulant. Exactly how it works is not known.

Important safety information:

Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.
Do NOT take more than the recommended dose without checking with your doctor.
If you are taking Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] for an attention deficit disorder, it should be used as a part of a treatment program that includes a variety of treatment measures.
If your condition does not get better within 1 month or if it gets worse, check with your doctor.
Serious effects, including heart attack, stroke, and sudden death, have occurred with the use of stimulant medicines in patients with heart defects or other serious heart problems. If you have a heart defect or another serious problem, talk with your doctor about other therapies to treat your condition.
Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] may cause a prolonged (more than 4 hours) or painful erection. This could happen even when you are not having sex. If this is not treated right away, it could lead to permanent sexual problems such as impotence. Contact your doctor right away if this happens.
Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] may cause circulation problems in the hands and feet. Tell your doctor if you have any numbness, pain, tingling, cold feeling, or skin color change (eg, from pale to blue or red) in your hands or feet. Call your doctor right away if you have any unexplained sores or wounds on your fingers or toes.
Tell your doctor or dentist that you take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] before you receive any medical or dental care, emergency care, or surgery.
Before you start any new medicine, check the label to see if it has a decongestant in it. If it does or if you are not sure, check with your doctor or pharmacist.
Lab tests, including blood pressure, heart function, complete blood cell counts, and platelet counts, may be performed while you use Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] may affect growth rate and weight gain in CHILDREN and teenagers in some cases. They may need regular growth and weight checks while they take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla].
Caution is advised when using Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] in CHILDREN; they may be more sensitive to its effects, especially loss of appetite, stomach pain, weight loss, trouble sleeping, and fast heartbeat.
Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] should not be used in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.
PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] while you are pregnant. It is not known if Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] is found in breast milk. If you are or will be breast-feeding while you use Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla], check with your doctor. Discuss any possible risks to your baby.

When used for long periods of time or at high doses, Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] stops working well. Do not take more than prescribed.
Some people who use Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Do not suddenly stop taking Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]. If you do, you may have WITHDRAWAL symptoms. These may include depression or other mental problems. If you need to stop Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla], your doctor will lower your dose over time.

Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] side effects

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; drowsiness; dry mouth; headache; indigestion; loss of appetite; nausea; nervousness; stomach pain; stuffy nose; trouble sleeping; vomiting; weight loss.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; joint pain; purple or brownish red spots on the skin; unusual hoarseness); blurred vision or other vision problems; chest, jaw, or arm pain; confusion; dark urine; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; hallucinations; new or worsening mental, mood, or behavior changes (eg, abnormal thoughts, aggression, agitation, anxiety, depression, hostility, irritability, panic attacks, persistent crying, restlessness, unusual sadness); one-sided weakness; seizures; severe or persistent dizziness or headache; shortness of breath; slurred speech; sudden, severe nausea or vomiting; suicidal thoughts or attempts; tremor; uncontrolled speech or muscle movements; unusual sweating; unusual tiredness or weakness; yellowing of the eyes or skin.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

Active ingredients: Methylphenidate

Select the most affordable brand or generic drug

Strength	Quantity	Price, USD	Country
9 HR Daytrana 1.11 MG/HR Transdermal System
9 HR Daytrana 2.22 MG/HR Transdermal Patch
9 HR Daytrana 3.33 MG/HR Transdermal System
9 HR Methylphenidate 1.11 MG/HR Transdermal Patch [Daytrana]
9 HR Methylphenidate 1.67 MG/HR Transdermal System
9 HR Methylphenidate 2.22 MG/HR Transdermal Patch
9 HR Methylphenidate 2.22 MG/HR Transdermal System [Daytrana]
9 HR Methylphenidate 3.33 MG/HR Transdermal Patch [Daytrana]
Apo-Methylphenidate
Aptensio XR
Aptensio XR extended-release capsules
Concerta XL
Cotempla 8.6 MG Disintegrating Oral Tablet
Cotempla XR-ODT 8.6 MG Extended Release Disintegrating Oral Tablet
Daytrana 1.1 MG/HR 9HR Transdermal System
Daytrana 15 MG per 9HR Transdermal Patch
Daytrana 20 MG/9HR Transdermal System
Daytrana 3.3 MG/HR 9HR Transdermal System
Equasym Retard
Equasym XL
Equasym XR
Medikinet LM
Metadate CD controlled-release capsules
Metadate ER
10 mg	30	$75.00
20 mg	30	$75.00
Methylin ER controlled-release tablets
Methylphenidate 8.6 MG Disintegrating Oral Tablet
Methylphenidate Sandoz
Methylphenidate chewable tablets
Methylphenidate extended-release capsules
Methylphenidate solution
Methylphenidate suspension
Metilfenidato Farmoz
Metrans XR
Omozín
Ritalin 1%
Ritalin LA
20 mg	9024 hour	$525.14	USA
40 mg	100 ,multiphasicrel.50-50	$612.51	USA
Ritalin LA extended-release capsules
Ritalina
Ritaline
Rubifen
Rubifen 10 mg x 200's		$48.00
Teva-Methylphenidate ER-C
methylphenidate 1.6 MG/HR per 9HR Transdermal System
methylphenidate 15 MG/9HR Transdermal System
methylphenidate 17.3 MG Extended Release Disintegrating Oral Tablet
methylphenidate 2.2 MG/HR 9HR Transdermal System
methylphenidate 3.3 MG/HR 9HR Transdermal System

References

Dailymed."Methylphenidate: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Dailymed."Cotempla xr-odt (methylphenidate) tablet, orally disintegrating [neos therapeutics, lp]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
"Methylphenidate". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).

Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] - Frequently asked Questions

Can Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

Who should not take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]?

Some medical conditions may interact with Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

if you are pregnant, planning to become pregnant, or are breast-feeding
if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
if you have allergies to medicines, foods, or other substances
if you have had an allergic reaction to dexmethylphenidate
if you have a history of high blood pressure, heart problems, blood vessel problems, or heart attack, or if a family member has a history of any of these problems or sudden death
if you have a history of seizures or abnormal electroencephalograms (EEGs)
if you have a history of an overactive thyroid, chronic fatigue, cystic fibrosis, or stomach or bowel problems (eg, blockage, inflammation, narrowing)
if you have a history of mood or mental problems (eg, agitation, anxiety, bipolar disorder, depression, psychosis, tension), abnormal thoughts, hallucinations, suicidal thoughts or attempts, or alcohol or other substance abuse or dependence, or if a family member has a history of any of these problems
if you have circulation problems in your hands or feet (eg, Raynaud phenomenon, thromboangiitis obliterans)

Some MEDICINES MAY INTERACT with Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]. Tell your health care provider if you are taking any other medicines, especially any of the following:

MAOIs (eg, phenelzine) because severe high blood pressure may occur
Anticoagulants (eg, warfarin), certain anticonvulsants (eg, phenobarbital, phenytoin, primidone), phenylbutazone, selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine), or tricyclic antidepressants (eg, imipramine) because the risk of their side effects may be increased by Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]
Medicines for high blood pressure (eg, guanethidine, metoprolol) because their effectiveness may be decreased by Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]

This may not be a complete list of all interactions that may occur. Ask your health care provider if Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How should I take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]?

Use Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] refilled.
Take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] by mouth 30 to 45 minutes before eating unless your doctor tells you otherwise.
You may have trouble sleeping while taking Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]. If this occurs, taking your last dose before 6 pm may help. Check with your doctor before you change the way that you take Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]. If trouble sleeping continues, talk with your doctor.
If you miss a dose of Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla], skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla].

Can Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla] be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

Reviews

Following the study conducted by gmedication.com on Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla], the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Methylphenidate 17.3 MG Disintegrating Oral Tablet [Cotempla]. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.